Privia Health Group, Inc. (PRVA)

Chimerix Stock Forecast

Stock Price Forecast

The 14 analysts that cover Chimerix stock have a consensus rating of "Strong Buy" and an average price target of $28.5, which forecasts a 51.11% increase in the stock price over the next year. The lowest target is $23 and the highest is $40.

Price Target: $28.50 (+51.11%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23	$28.5	$28	$40
Change	+21.95%	+51.11%	+48.46%	+112.09%

Analyst Ratings

The average analyst rating for Chimerix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	6	6	5	4	4	4
Buy	10	9	9	9	9	9
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	16	15	14	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Buy Maintains $30 → $28	Buy	Maintains	$30 → $28	+48.46%	Jul 9, 2025
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $29 → $32	Buy	Maintains	$29 → $32	+69.67%	May 28, 2025
Andrew Mok Barclays	Barclays	Hold Maintains $23 → $24	Hold	Maintains	$23 → $24	+27.25%	May 27, 2025
Constantine Davides JMP Securities	JMP Securities	Buy Reiterates $29	Buy	Reiterates	$29	+53.76%	Apr 28, 2025
Michael Ha Baird	Baird	Buy Maintains $24 → $26	Buy	Maintains	$24 → $26	+37.86%	Apr 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.31B

Increased by 90.45%

from 1.74B

Revenue Next Year

3.66B

Increased by 10.52%

from 3.31B

EPS This Year

0.21

Increased by 90.75%

from 0.11

EPS Next Year

0.34

Increased by 62.51%

from 0.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	817.08M	966.22M	1.36B	1.66B	1.74B	3.31B	3.66B	4.12B
Revenue Growth	3.91%	18.25%	40.41%	22.19%	4.75%	90.45%	10.52%	12.75%
EPS	0.33	-1.83	-0.08	0.19	0.11	0.21	0.34	0.47
EPS Growth	278.92%	-	-	-	-42.11%	90.75%	62.51%	38.46%
Forward PE	-	-	-	-	-	89.88	55.31	39.95
No. Analysts	-	-	-	-	-	24	24	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.5B	4.0B	4.6B
Avg	3.3B	3.7B	4.1B
Low	3.1B	3.4B	3.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	98.9%	20.2%	26.1%
Avg	90.5%	10.5%	12.7%
Low	81.0%	3.5%	1.8%

EPS Forecast

EPS	2025	2026	2027
High	0.30	0.44	0.58
Avg	0.21	0.34	0.47
Low	0.12	0.25	0.39

EPS Growth

EPS Growth	2025	2026	2027
High	176.8%	110.2%	69.4%
Avg	90.7%	62.5%	38.5%
Low	6.9%	16.8%	15.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.